Matt Dellatorre

Stock Analyst at Goldman Sachs

(2.60)

# 2,025

Out of 5,154 analysts

5

Total ratings

75%

Success rate

25.07%

Average return

Main Sectors:

Top Industries:

Drug Manufacturers - Specialty & Generic

Stocks Rated by Matt Dellatorre

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	TEVA Teva Pharmaceutical Industries	Maintains: Buy	$36 → $45	$31.05	+44.93%	4	Feb 9, 2026
	VTRS Viatris	Initiates: Neutral	$10	$14.16	-29.38%	1	Jun 6, 2025

Teva Pharmaceutical Industries

Feb 9, 2026

Maintains: Buy

Price Target: $36 → $45

Current: $31.05

Upside: +44.93%

Viatris

Jun 6, 2025

Initiates: Neutral

Price Target: $10

Current: $14.16

Upside: -29.38%